NCT01024998: Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) |
|
|
| Completed | 1 | 19 | US | AAV2-sFLT01 | Genzyme, a Sanofi Company | Macular Degeneration, Age-Related Maculopathies, Age-Related Maculopathy, Maculopathies, Age-Related, Maculopathy, Age-Related, Retinal Degeneration, Retinal Neovascularization, Gene Therapy, Therapy, Gene, Eye Diseases | 07/14 | 07/18 | | |
